BNP PARIBAS FINANCIAL MARKETS - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 272 filers reported holding NEOGENOMICS INC in Q1 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.5%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$2,642,077
-9.7%
214,803
+18.0%
0.00%
-25.0%
Q2 2023$2,925,801
-1.3%
182,066
+6.9%
0.00%0.0%
Q1 2023$2,964,523
+428.0%
170,277
+180.2%
0.00%
+300.0%
Q4 2022$561,432
-99.8%
60,761
+51.4%
0.00%0.0%
Q2 2022$327,190,000
-18.1%
40,146
+22.1%
0.00%0.0%
Q1 2022$399,468,000
-79.0%
32,878
-40.9%
0.00%
-66.7%
Q4 2021$1,897,925,000
-76.1%
55,625
-53.6%
0.00%
-72.7%
Q3 2021$7,935,914,000
+285.9%
119,959
+163.5%
0.01%
+266.7%
Q2 2021$2,056,635,000
+65.0%
45,531
+76.2%
0.00%
+50.0%
Q1 2021$1,246,167,000
+4.9%
25,838
+17.1%
0.00%0.0%
Q4 2020$1,188,249,000
+21.0%
22,070
-17.1%
0.00%
+100.0%
Q3 2020$982,418,000
+256.8%
26,631
+199.6%
0.00%
Q2 2020$275,350,000
-75.7%
8,888
-78.4%
0.00%
-100.0%
Q1 2020$1,134,578,000
+40.6%
41,093
+49.0%
0.00%
+100.0%
Q4 2019$806,715,000
+146.0%
27,580
+60.8%
0.00%0.0%
Q3 2019$327,984,000
+35.9%
17,154
+56.0%
0.00%
Q2 2019$241,296,000
-31.0%
10,998
-35.7%
0.00%
-100.0%
Q1 2019$349,805,000
+126183.4%
17,097
+77613.6%
0.00%
Q4 2018$277,000
-99.0%
22
-98.8%
0.00%
Q3 2018$28,889,000
+4.7%
1,882
-10.6%
0.00%
Q2 2018$27,583,000
-71.9%
2,104
-82.5%
0.00%
Q1 2018$98,189,000
-7.9%
12,033
-0.0%
0.00%
Q4 2017$106,621,000
+79.0%
12,034
+124.8%
0.00%
Q3 2017$59,579,000
+15.1%
5,353
-7.3%
0.00%
Q2 2017$51,753,000
+2789.6%
5,776
+2444.5%
0.00%
Q1 2017$1,791,000
-92.6%
227
-92.0%
0.00%
Q4 2016$24,347,000
-17.2%
2,841
-20.6%
0.00%
Q3 2016$29,419,000
+78.0%
3,579
+74.1%
0.00%
Q2 2016$16,530,000
-80.0%
2,056
-80.4%
0.00%
Q4 2015$82,588,000
+20.4%
10,494
-12.4%
0.00%
Q3 2015$68,617,000
+184.8%
11,975
+168.9%
0.00%
Q2 2015$24,096,000
+453.2%
4,454
+239.5%
0.00%
Q2 2014$4,356,000
-10.1%
1,312
-10.4%
0.00%
Q1 2014$4,846,000
-24.5%
1,464
-17.4%
0.00%
Q4 2013$6,415,000
-79.8%
1,772
-83.2%
0.00%
Q3 2013$31,680,000
-39.5%
10,560
-19.7%
0.00%
Q2 2013$52,345,00013,1520.00%
Other shareholders
NEOGENOMICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Kopp Family Office, LLC 2,023,355$91,395,00037.83%
Blue Water Life Science Advisors, LP 702,222$31,719,00011.94%
Burrage Capital Management LLC 147,921$6,682,0006.70%
PERKINS CAPITAL MANAGEMENT INC 158,300$7,150,0004.06%
First Light Asset Management, LLC 1,148,945$51,898,0003.11%
Soleus Capital Management, L.P. 352,007$15,900,0002.44%
Ranger Investment Management 832,286$37,594,0001.96%
Avidity Partners Management LP 1,367,000$61,747,0001.67%
Bullseye Asset Management LLC 108,672$4,909,0001.65%
Tygh Capital Management, Inc. 255,541$11,543,0001.57%
View complete list of NEOGENOMICS INC shareholders